|
C20ORF24 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.51052520386474E-13 |
| Normal-vs-Stage2 |
3.9876999999966E-05 |
| Normal-vs-Stage3 |
2.20249999999256E-05 |
| Normal-vs-Stage4 |
2.96909999997208E-06 |
| Stage1-vs-Stage2 |
7.376800E-01 |
| Stage1-vs-Stage3 |
1.246100E-02 |
| Stage1-vs-Stage4 |
7.696200E-03 |
| Stage2-vs-Stage3 |
2.985800E-02 |
| Stage2-vs-Stage4 |
7.624300E-02 |
| Stage3-vs-Stage4 |
3.166200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62458935193399E-12 |
| Normal-vs-AfricanAmerican |
3.32900373933853E-12 |
| Normal-vs-Asian |
8.027900E-02 |
| Caucasian-vs-AfricanAmerican |
1.536600E-01 |
| Caucasian-vs-Asian |
3.249200E-01 |
| AfricanAmerican-vs-Asian |
2.543600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62436730732907E-12 |
| Normal-vs-Female |
8.07609534803078E-11 |
| Male-vs-Female |
1.490040E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.54091999999828E-05 |
| Normal-vs-Extreme_Weight |
5.83270098886146E-11 |
| Normal-vs-Obese |
3.63190000296498E-08 |
| Normal-vs-Extreme_Obese |
3.227800E-02 |
| Normal_Weight-vs-Extreme_Weight |
9.932400E-01 |
| Normal_Weight-vs-Obese |
7.862200E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.918400E-01 |
| Extreme_Weight-vs-Obese |
7.319000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.300000E-01 |
| Obese-vs-Extreme_Obese |
4.268000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.280800E-03 |
| Normal-vs-Age(41-60Yrs) |
1.94655402907529E-12 |
| Normal-vs-Age(61-80Yrs) |
2.22044604925031E-16 |
| Normal-vs-Age(81-100Yrs) |
1.419890E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.776000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.064200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.259600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.838800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.044600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.157200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62536650805123E-12 |
| Normal-VS-Type2 PRCC |
2.64040000974575E-09 |
| Normal-VS-KIRP CIMP |
6.432400E-04 |
| Normal-VS-Unclassified PRCC |
1.63610000003533E-06 |
| Type1 PRCC-VS-Type2 PRCC |
2.771800E-02 |
| Type1 PRCC-VS-KIRP CIMP |
6.576600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.319400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.530000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.312000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.849400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.31379999995995E-07 |
| Normal-vs-N1 |
2.33309999999598E-05 |
| Normal-vs-N2 |
1.928390E-01 |
| N0-vs-N1 |
1.558400E-01 |
| N0-vs-N2 |
4.535200E-01 |
| N1-vs-N2 |
9.550400E-01 |
|
|
